Review
doi: 10.1007/s00345-002-0246-7.
Tamsulosin: an overview
Affiliations
- PMID: 12022708
- DOI: 10.1007/s00345-002-0246-7
Item in Clipboard
Review
Tamsulosin: an overview
World J Urol.
2002 Apr.
Abstract
This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent. Currently, there are no adequate studies that effectively compare existing agents for the treatment of benign prostatic hyperplasia using a randomised, placebo-controlled design with adequate numbers and this needs to be addressed in future studies.
Similar articles
-
Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses.Br J Urol. 1997 Oct;80(4):606-11. doi: 10.1046/j.1464-410x.1997.00411.x. Br J Urol. 1997. PMID: 9352700 Clinical Trial.
-
[Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only].Hinyokika Kiyo. 1998 Aug;44(8):565-73. Hinyokika Kiyo. 1998. PMID: 9783192 Japanese.
-
Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.BJU Int. 2005 May;95(7):1006-12. doi: 10.1111/j.1464-410X.2005.05456.x. BJU Int. 2005. PMID: 15839922 Clinical Trial.
-
Tamsulosin for the treatment of benign prostatic hypertrophy.Ann Pharmacother. 2000 Feb;34(2):188-99. doi: 10.1345/aph.18263. Ann Pharmacother. 2000. PMID: 10676828 Review.
-
Tamsulosin: current clinical experience.Urology. 2001 Dec;58(6 Suppl 1):42-8; discussion 48. doi: 10.1016/s0090-4295(01)01346-2. Urology. 2001. PMID: 11750250 Review.
Cited by
-
Tamsulosin-induced life-threatening hypotension in a patient with spinal cord injury: A case report.World J Clin Cases. 2022 Sep 6;10(25):9142-9147. doi: 10.12998/wjcc.v10.i25.9142. World J Clin Cases. 2022. PMID: 36157672 Free PMC article.
-
Effects of ρ-Da1a a peptidic α(1) (A) -adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats.Br J Pharmacol. 2013 Feb;168(3):618-31. doi: 10.1111/j.1476-5381.2012.02231.x. Br J Pharmacol. 2013. PMID: 23005263 Free PMC article.
-
2-Phenethylamines in Medicinal Chemistry: A Review.Molecules. 2023 Jan 14;28(2):855. doi: 10.3390/molecules28020855. Molecules. 2023. PMID: 36677913 Free PMC article. Review.
-
Evaluation of the Effect of an α-Adrenergic Blocker, a PPAR-γ Receptor Agonist, and a Glycemic Regulator on Chronic Kidney Disease in Diabetic Rats.Int J Mol Sci. 2024 Oct 23;25(21):11372. doi: 10.3390/ijms252111372. Int J Mol Sci. 2024. PMID: 39518925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
